Numerical Simulation of the Inhibitory Effect of Angiostatin on Metastatic Tumor Angiogenesis and Microenvironment

Bulletin of Mathematical Biology

Volumn 75, Issue 2, 2013, Pages 274-287

  Zhao, Gaiping ^a   Yan, Wentao ^a   Chen, Eryun ^a   Yu, Xiaoli ^b   Cai, Wenjie ^a  

^a UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Angiogenesis; Angiostatin; Inhibitory effect; Metastatic tumor; Microenvironment

Indexed keywords

EID: 84873746361     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-012-9805-2     Document Type: Article

References (23)

1. Alarcón, T., Owen, M. R., Byrne, H. M., & Maini, P. K. (2006). Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy. Comput. Math. Methods Med., 7(2-3), 85-119.
2. Anderson, A. R. A., & Chaplain, M. A. J. (1998). Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol., 60, 857-900.
3. Anderson, A. R. A., & Chaplain, M. A. J. (2000). A gradient-driven mathematical model of antiangiogenesis. Math. Comput. Model., 32, 1141-1152.
4. Aubert, M., Chaplain, M. A. J., McDougall, S. R., Devlin, A., & Mitchell, C. A. (2011). A continuum mathematical model of the developing murine retinal vasculature. Bull. Math. Biol. doi: 10. 1007/s11538-011-9631-y.
5. Baxter, L. T., & Jain, R. K. (1989). Transport of fluid and macromolecules in tumors I. Role of interstitial pressure and convection. Microvasc. Res., 37, 77-104.
6. Cai, Y., Wu, J., Gulnan, K., Zhang, H., Cao, J., Xu, S., Long, Q., & Collons, M. W. (2009). Numerical simulation of solid tumor angiogenesis with Endostatin treatment: a combined analysis of inhibiting effect of anti-angiogenic factor and micro mechanical environment of extracellular matrix. Appl. Math. Mech., 30(10), 1247-1254.
7. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285(10), 1182-1186.
8. Fukumura, D., & Jain, R. K. (2007). Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc. Res., 74, 72-84.
9. Jain, R. K., Tong, R. T., & Munn, L. L. (2007). Effect of vascular normalization by antiangiogenic therapy on inerstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res., 67(6), 2729-2735.
10. Konjevic, G., & Stankovic, S. (2006). Matrix metalloproteinases in the process of invasion and metastasis of breast cancer. Arch. Oncol., 14(3-4), 136-140.
11. Kuszyk, B. S., Corl, F. M., Franano, F. N., Bluemke, D. A., Hofmann, L. V., Fortman, B. J., & Fishman, E. K. (2001). Tumor transport physiology: Implications for imaging and imaging-guided therapy. Am. J. of Radiol., 177, 747-753.
12. Madu, C. O., & Lu, Y. (2009). Tumor microvasculature and microenvironment: therapeutic targets for inhibition of tumor angiogenesis and metastasis. In Pharmaceutical perspectives of cancer therapeutics. New York: Springer.
13. Maggelakis, S. A. (1996). The effects of tumor angiogenesis factor (TAF) and tumor inhibitor factors (TIFs) on tumor vascularization: a mathematical model. Math. Comput. Model., 23(6), 121-133.
14. McDougall, S. R., Anderson, A. R. A., Chaplain, M. A. J., & Sherratt, J. A. (2002). Mathematical modeling of flow through vascular network: implications for tumor-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol., 64, 673-702.
15. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y. H., Sage, E. H., & Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell., 79(2), 315-328.
16. Sim, B. K. L., O'Reilly, M. S., Liang, H., Fortier, A. H., He, W., Madsen, J. W., Lapcevich, R., & Nacy, C. A. (1997). A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res., 57, 1329-1334.
17. Soff, G. A. (2000). Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev., 19, 97-107.
18. Stephanou, A., McDougall, S. R., Anderson, A. R. A., & Chaplain, M. A. J. (2005). Mathematical modelling of flow in 2D and 3D vascular networks: applications to anti-angiogenic and chemotherapeutic drug strategies. Math. Comput. Model., 41, 1137-1156.
19. Tao, K. S., Dou, K. F., & Wu, X. A. (2004). Expression of angiostatin cDNA in human hepatocellular carcinoma cell line SMMC-7721 and its effect on implanted carcinoma in nude mice. World J. Gastroenterol, 10, 1421-1424.
20. Tee, D., & DiStefano, J. (2004). Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies. J. Cancer Res. Clin. Oncol., 130, 15-24.
21. Wu, J., Ding, Z., Cai, Y., Xu, S., Zhao, G., & Quan, L. (2011). Simulation of tumor microvasculature and microenvironment response to anti-angiogenic treatment by angiostatin and endostatin. Appl. Math. Mech., 32(4), 437-448.
22. Zhao, G., Gao, H., Wu, J., Xu, S., Collons, M. W., Long, Q., Carola, K., & Padhani, A. R. (2006). 2D numerical simulation of effect of antiangiogenic factors Angiostatin and Endostatin on tumor-induced angiogenesis. J. Med. Biomech., 21(4), 272-279.
23. Zheng, X., Wise, S. M., & Cristini, V. (2005). Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Bull. Math. Biol., 67, 211-259.